Programme overview
The HMV UK Meeting provides a multi-disciplinary network for established clinicians and healthcare professionals that are either caring for patients dependent on home mechanical ventilation, or that have an interest in continual care using highly advanced specialist technologies.
This meeting offers an invaluable opportunity to learn more about the latest advances in the management of children and adults with chronic respiratory failure. The HMV UK Meeting is also renowned for providing respiratory professionals and experts from around the country with the opportunity to network and knowledge share.
Who should attend
This one day meeting is ideal for those working with patients with chronic respiratory failure. This includes, but is not limited to, consultants in respiratory and critical care, rehabilitation medicine, sleep medicine and neurology, specialist registrars, therapists and clinical nurse specialists.
Format
The meeting brings experts from around the UK to present lectures, clinical trial updates, case studies, and interactive Q&A sessions. HMV UK has been designed to provide many opportunities for open discussions between healthcare professionals.
Draft agenda 2024
How to book
2023 Meeting highlights
Exhibitors
Philips
At Philips, we look beyond technology to the experiences of consumers, patients, providers and caregivers. We unlock insights leading to innovative solutions that help deliver improved patient experience, better health outcomes, improved staff experience, and lower cost of care. With leading research, design and innovation capabilities, we partner with our customers to transform the delivery of healthcare.
Radiometer Limited
Founded in 1935, we are now a world leading provider of technologically advanced point-of-care solutions, designed to simplify and automate all phases of acute care testing.
Since launching the world’s first commercially available blood gas analyser in 1954, we continue to build on a legacy of innovation.
Our mission: To help caregivers make diagnostic decisions that save lives.
Our vision: Improving global healthcare with reliable, fast and easy patient diagnoses.
Our portfolio:
• Blood gas analysis on the ABL90 FLEX PLUS, a compact analyser that measures 19 key parameters (including creatinine and urea) via a single 65µL blood sample, in 35 seconds.
• Immunoassay testing on the AQT90 FLEX, a benchtop analyser that measures; Cardiac, Coagulation, Infection, Inflammation and Pregnancy biomarkers via whole blood samples between 11-21 minutes, using a standard EDTA or Lithium Heparin vacutainer.
• Vendor neutral connectivity via our AQURE data management system, helping with the governance and compliance requirements for point-of-care testing.
• Blood gas sampler solutions in our safePICO and safeClinitube range, helping minimise pre-analytical errors in both syringe and capillary sampling.
• For respiratory and neonatal medicine, transcutaneous carbon dioxide, and oxygen/oxygen saturation monitoring on the TCM5, a table-top monitor providing non-invasive, continuous information on a patient’s oxygenation and ventilation status.
By providing fast and accurate results, healthcare professionals can make immediate, well-informed decisions enabling them to improve patient care and optimise patient flow.
Email: sales@radiometer.co.uk
Website: www.radiometer.co.uk and ww.acutecaretesting.org
ResMed
ResMed is a global pioneer in innovative solutions that treat and keep people out of the hospital, empowering them to live healthier, higher-quality lives. Our ecosystem of cloud-connected medical devices help transform care for people with sleep apnoea, and other chronic diseases, while our digital health technologies drive new efficiencies in population health management.
The healthcare environment in the UK is evolving rapidly. As the population ages, chronic diseases are becoming more common. As a result, there is increased pressure on the healthcare industry and providers. ResMed is stepping up to the challenge and creating a future where healthcare is faster, more effective and more efficient. We’re connecting data, connecting patients and connecting healthcare to facilitate care and improve the therapy experience.
With more than 20.5 million cloud-connectable devices worldwide providing medical sleep and respiratory data, we are continuously working to reduce the impact of chronic disease and lower costs for consumers and healthcare systems.
Telemonitoring is particularly appropriate for the management of chronic, progressive conditions that require regular clinical follow-up, such as neuromuscular disease and chronic obstructive pulmonary disease (COPD).
AirView, our cloud-based patient monitoring system, connects to ResMed’s sleep, ventilation and high-flow therapy (HFT) devices so you can manage and support patients on these different treatments via the same platform.
Our comprehensive out-of-hospital software platforms support the professionals and caregivers who help people stay healthy in the home or care setting of their choice.
Sanofi
At Sanofi, we chase the miracles of science to improve people’s lives.
Sanofi’s Rare Disease franchise focuses on lysosomal storage disorders (LSDs) including Pompe, Fabry and Gaucher disease and other rare conditions such as acquired thrombotic thrombocytopenic purpura (aTTP).
Patients with rare diseases can endure a long journey involving numerous tests, misdiagnoses, and visits to different departments.
Focusing on uncommon and underserved medical conditions, Sanofi’s Rare Disease franchise empowers the lives of people with rare diseases with health care options that are highly specialised and can be transformative.
Sentec
